Xiaoping Jin

Title: Innovations of Xiaoping Jin in Tumor Biomarkers

Introduction

Xiaoping Jin is an accomplished inventor based in Hillsborough, NJ, known for his significant contributions to the field of biomarker research. With a total of two patents, his work focuses on innovative methods for identifying and treating tumors and other diseases.

Latest Patents

Xiaoping Jin's latest patents include groundbreaking inventions related to protein and nucleic acid biomarkers. The first patent, titled "Protein biomarker and uses thereof," outlines methods for assessing HRG gene expression at a protein level in human subjects. This invention provides a framework for administering treatments, such as anti-HER3 antibodies, based on the levels of HRG gene expression. The second patent, "Nucleic acid biomarker and use thereof," similarly focuses on HRG gene expression but at the mRNA level. This invention also guides treatment decisions based on the assessed levels of HRG gene expression.

Career Highlights

Throughout his career, Xiaoping Jin has worked with prominent companies in the pharmaceutical industry, including Daiichi Sankyo Company, Limited and Amgen Inc. His experience in these organizations has contributed to his expertise in biomarker research and development.

Collaborations

Xiaoping Jin has collaborated with notable professionals in his field, including Matthias Schneider and Sabine Blum. These partnerships have further enhanced his research and innovation capabilities.

Conclusion

Xiaoping Jin's contributions to the field of biomarker research demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of identifying and treating tumors effectively.